Leishmaniasis - 69 Studies Found Completed : A Community Trial for Visceral Leishmaniasis (VL) : Visceral Leishmaniasis : 2010-02-14 : Drug: Albendazole, Iron, Zinc and Vitamin A Completed : Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa : Primary Visceral Leishmaniasis : 2010-02-10 : Drug: Liposomal amphotericin B (AmBisome®) and sodium stibogluconate Completed : Efficacy, Acceptability and Cost-effectiveness of Long Lasting Insecticide Nets (LLIN) in the Prevention of Kala Azar : Visceral Leishmaniasis Kala Azar : 2006-04-25 : Device: Long Lasting Impregnated Nets (LLIN) Distribution of LLIN in selected clusters Completed : Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis : Visceral Leishmaniasis : 2005-09-13 : Drug: Paromomycin sulfate Drug: Amphoteric Completed : Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern Africa : Visceral Leishmaniasis : 2015-04-20 : Drug: Miltefosine Not yet recruiting : Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa : Visceral Leishmaniasis : 2017-04-21 : Drug: Miltefosine Miltefosine Completed : Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis : Visceral Leishmaniasis : 2008-06-11 : Drug: Amphotericin B Deoxycholate Completed : A Study to Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL) : Post-kala-azar Dermal Leishmaniasis : 2013-10-23 : Drug: Mitefosine Tablet Miltefosine 100 mg in two devided doses for 12 weeks RECRUITING : Intralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous Leishmaniasis : Leishmaniasis, Cutaneous : 2024-11-22 : Sessions will be held once weekly for a maximum of 6 weeks <<< Previous
